CDK6 mediates the effect of attenuation of miR-1 on provoking cardiomyocyte hypertrophy

Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy

(2015) Shuai Huang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis

(2015) Haibing Xiao et al.   Oncotarget

MicroRNA-1 Downregulation Increases Connexin 43 Displacement and Induces Ventricular Tachyarrhythmias in Rodent Hypertrophic Hearts

(2013) Antonio Curcio et al.   PLoS One

Role of D-type cyclins in heart development and disease

(2012) Adam Hotchkiss et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

MicroRNAs in control of cardiac hypertrophy

(2012) Paula A. Da Costa Martins et al.   CARDIOVASCULAR RESEARCH

miR-1/miR-206 regulate Hsp60 expression contributing to glucose-mediated apoptosis in cardiomyocytes

(2010) Zhi-Xin Shan et al.   FEBS LETTERS

Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy

(2010) Q. Li et al.   JOURNAL OF CELL SCIENCE

MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice

(2009) Thomas E. Callis et al.   JOURNAL OF CLINICAL INVESTIGATION

MicroRNA-1 Negatively Regulates Expression of the Hypertrophy-Associated Calmodulin and Mef2a Genes

(2009) S. Ikeda et al.   MOLECULAR AND CELLULAR BIOLOGY

Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction

(2008) Arintaya Phrommintikul et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Phosphorylation of pRb by cyclin D kinase is necessary for development of cardiac hypertrophy

(2008) R. Hinrichsen et al.   CELL PROLIFERATION